feed,title,long_url,short_url
Benzinga,Arch Oncology Presents New Preclinical Data on Highly Differentiated Anti-CD47 Antibody AO-176 at ASH 2020,https://www.benzinga.com/pressreleases/20/12/g18664991/arch-oncology-presents-new-preclinical-data-on-highly-differentiated-anti-cd47-antibody-ao-176-at-,https://j.mp/39Or68S
